Magnetic resonance imaging of stem cell apoptosis in arthritic joints with a caspase activatable contrast agent

ACS Nano. 2015 Feb 24;9(2):1150-60. doi: 10.1021/nn504494c. Epub 2015 Jan 26.

Abstract

About 43 million individuals in the U.S. encounter cartilage injuries due to trauma or osteoarthritis, leading to joint pain and functional disability. Matrix-associated stem cell implants (MASI) represent a promising approach for repair of cartilage defects. However, limited survival of MASI creates a significant bottleneck for successful cartilage regeneration outcomes and functional reconstitution. We report an approach for noninvasive detection of stem cell apoptosis with magnetic resonance imaging (MRI), based on a caspase-3-sensitive nanoaggregation MRI probe (C-SNAM). C-SNAM self-assembles into nanoparticles after hydrolysis by caspase-3, leading to 90% amplification of (1)H MR signal and prolonged in vivo retention. Following intra-articular injection, C-SNAM causes significant MR signal enhancement in apoptotic MASI compared to viable MASI. Our results indicate that C-SNAM functions as an imaging probe for stem cell apoptosis in MASI. This concept could be applied to a broad range of cell transplants and target sites.

Keywords: MRI; apoptosis; arthritis; molecular imaging; nanoparticles; stem cell.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis*
  • Arthritis / diagnosis
  • Arthritis / pathology*
  • Arthritis / surgery
  • Caspase 3 / metabolism*
  • Contrast Media / chemistry*
  • Contrast Media / metabolism
  • Female
  • Hydrolysis
  • Joints / pathology*
  • Magnetic Resonance Imaging / methods*
  • Nanoparticles / chemistry
  • Rats
  • Stem Cell Transplantation
  • Stem Cells / cytology*

Substances

  • Contrast Media
  • Caspase 3